Financials
- Market Capitalization 2.16 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
—
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1880 | IMNM Immunome, Inc. - Common Stock | 19.67 USD | +0.61% | -7.22% | -19.71% | +41.31% | 2.23 B USD | ||
| 1887 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.58 USD | -0.42% | +4.94% | +2.73% | +38.98% | 2.21 B USD | ||
| 1897 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.33 USD | -2.57% | +4.13% | +1.96% | +15.21% | 2.13 B USD | ||
| 1918 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 29.12 USD | -2.54% | -2.28% | -17.06% | -2.08% | 2.10 B USD |